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ABSTRACT
Objective: The goal of this study was to determine if meconium staining of the amniotic fluid
(MSAF) is a marker for chorioamnionitis.
Methods: In a retrospective, case-control investigation, we studied 100 patients with MSAF. Each
patient was matched with a control who delivered during the same period but did not have MSAF.
Subjects and controls were matched for age, parity, gestational age, mode of delivery, duration of
rupture of membranes (ROM), length of internal monitoring, and number of examinations before
and after ROM. The incidence of chorioamnionitis in controls and study patients was compared.
The diagnosis ofchorioamnionitis was based on clinical examination.
Results: Thirteen of the 200 patients [6.5%, 95% confidence interval (CI), 2.5-10.5%] developed
chorioamnionitis. Of the 100 women with MSAF, 10 (10%, 95% CI, 4-16) were infected compared
with only 3 controls (3%, 95% CI, 0-6, P 0.04). The odds ratio (OR) for this comparison was 3.3,
and the 95% CI was 1.02-10.63.
Conclusions: MSAF is associated with an increased frequency of chorioamnionitis. Several fac-
tors could explain this association. Infection may cause fetal stress, leading to the release of meco-
nium. MSAF may enhance the growth of bacteria by providing a rich medium of essential nutrients
or growth stimulants. MSAF also may impair the host immune system so that chemotaxis or
phagocytosis is diminished, thus allowing accelerated growth of microorganisms.
(C) 1995 Wiley-Liss, Inc.
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Approximately 0.5-2% of all term pregnancies are
complicated by chorioamnionitis. This condition
is associated with a higher frequency of cesarean
delivery, prolonged maternal febrile morbidity,
and an increased rate of neonatal infection, all of
which result in prolonged hospitalization and ex-
pense for mother and neonate. Several important
risk factors for chorioamnionitis have been identi-
fied, including the length of labor, duration of
rupture of membranes (ROM), duration of inter-
nal monitoring, socioeconomic status of patient,
preexisting genital-tract infection, and the number
of vaginal examinations. The presence of meco-
nium-stained amniotic fluid (MSAF) may be a sign
of fetal stress and is associated with the possibility of
meconium aspiration syndrome, but its association
with chorioamnionitis has not been precisely de-
fined
2-s We undertook the following case-control
study to determine ifterm patients with MSAF had
an increased risk of chorioamnionitis.
MATERIALS AND METHODS
In a retrospective, case-control investigation, we
studied 200 pregnant women with singleton term
pregnancies from the obstetrics service at Shands
Hospital, University of Florida, during the period
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from January 1991 to May 1993. The patients
were predominantly from low socioeconomic back-
grounds. One hundred asymptomatic women with
MSAF were identified using our computerized per-
inatal database. Each of these women was matched
to a control who delivered during the same period
but who did not have MSAF. Possible controls
were initially identified by a review of the labor and
delivery birth log and then confirmed by an assess-
ment ofthe complete hospital record. Controls were
matched to cases for demographic and clinical vari-
ables recognized as risk factors for chorioamnioni-
tis. 6’7 The matching variables included age (+3
years), parity (nulliparous, 1-2, 3-5, >5), mode
of delivery (vaginal vs. cesarean), length ofROM
(<6, 6-12, 13-18, > 18 h), length of internal
monitoring (0-6, 7-12, >12 h), and number of
pelvic examinations both before and after ROM
(<4, 4-6, >6).
Patients who presented to the labor-and-delivery
suite with overt infection or who were receiving
antibiotics at the time of admission were excluded
from the study and control groups. Patients were
also excluded if they had abnormal presentations.
The diagnosis of chorioamnionitis was based on
all of the following clinical criteria: maternal tem-
perature >38.0C, fetal or maternal tachycardia,
and uterine tenderness in the absence of any other
localizing signs of infection. The patients with
chorioamnionitis were treated with intravenous (IV)
antibiotics, usually ampicillin plus gentamicin, as
soon as the diagnosis was established, unless deliv-
ery was imminent. In the latter case, antibiotics
were administered after the infant’s umbilical cord
was clamped. Clinicians caring for the patients were
unaware of the intent of this investigation. At the
time of the study, MSAF was not considered an
indication for microbiologic assessment of the am-
niotic flud or empiric antibiotic treatment.
The differences between the study and control
groups were compared using the uncorrected chi-
squared test. Ninety-five percent confidence inter-
vals (CI) and odds ratios (OR) were also calculated,
when appropriate. P < 0.05 was considered statis-
tically significant.
RESULTS
Thirteen of 200 patients (6.5%, 95% CI, 2.5-
10.5) developed chorioamnionitis. Eleven (85%)
of these patients were younger than 25 years and 10
(77%) were nulliparous. All had ROM for >6 h
and 12 (92%) had internal monitoring >6 h. All
had >4 vaginal examinations after ROM.
Chorioamnionitis was significantly more com-
mon in patients with MSAF than in patients with
clear fluid. Of the 100 women with MSAF, 10
(10%, 95% CI, 4-16) were infected compared with
only 3 controls (3%, 95% CI, 0-6, P 0.04).
The OR for this comparison was 3.3, and the 95%
CI for the OR was 1.02-10.63.
DISCUSSION
The results of this investigation demonstrate a sig-
nificant increase in the incidence of chorioamnion-
itis in term patients with MSAF (10%) compared
with carefully matched controls without MSAF
(3%). In considering the significance of this find-
ing, we acknowledge that our study has potential
shortcomings. First, the study design was retro-
spective. Second, we did not routinely culture ei-
ther the lower genital tract or amniotic fluid in
cases or controls. Therefore, there is a possibility
that, despite careful matching for clinical variables,
the 2 groups may have differed with respect to
frequency of colonization by genital-tract patho-
gens. Third, our overall frequency of chorioam-
nionitis was relatively high compared with other
reports in the literature. This finding is most likely
due to the high prevalence ofgroup B streptococcal
colonization and bacterial vaginosis in our popula-
tion. In previous investigations, we reported the
prevalence of these 2 infections to be 26% and
30%, respectively. 8’9 Both of these infections are
recognized as important independent risk factors
for chorioamnionitis.
Despite the caveats noted above, our observa-
tions are supported by a previous study by Wen
et al.,
10 who found an 8% incidence of chorioam-
nionitis in term patients with MSAF compared
with 2% in patients without MSAF. This study
predominantly consisted of an African-American
and Mexican-American population. Although the
authors did not specifically match subjects and con-
trols for age, parity, gestational age, mode of deliv-
ery, length ofROM, duration of fetal monitoring,
and number of pelvic examinations, the groups
were relatively comparable with respect to these
variables.
Previous reports by Romero et al.
5 and Marko-
vitch and coworkers
11 also identified MSAF as a
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risk factor for intraamniotic infection in patients
having preterm delivery. Romero et al. s studied 3 0
patients with preterm labor and MSAF, detected
by transabdominal amniocentesis, and 677 preterm
patients with clear amniotic fluid. They reported a
significantly higher rate of positive amniotic-fluid
cultures in patients with MSAF compared with
patients with clear fluid (33% vs. 11%,
P 0.001). Markovitch et al.
11 evaluated 89 pa-
tients with premature delivery and MSAF and an
equal number with premature delivery and clear
amniotic fluid. The prevalence of clinical chorio-
amnionitis was higher in patients with MSAF than
in patients with clear fluid (6% vs. 0%, P 0.03).
In addition, they found that histologic chorioam-
nionitis was significantly higher in patients with
MSAF (11.2% vs. 0%, P 0.03).
These data plus our own findings suggest that
there is an association between MSAF and chorio-
amnionitis. Two explanations for this association
seem plausible. First, microorganisms swallowed
by the fetus may induce gastrointestinal motility
and meconium passage. Investigators studying the
association of intraamniotic infection with Listeria
monocytogenes and MSAF proposed that the inges-
tion of infected amniotic fluid leads to fetal enteritis
with subsequent meconium passage.
12 Although L.
monocytogenes is not a common pathogen in term
patients with chorioamnionitis, Romero et al.
13
have demonstrated that bacterial endotoxin is more
commonly found in MSAF than in clear amniotic
fluid (19.3% vs. 3.4%, P < 0.001). Therefore,
perhaps bacteria or endotoxins present in amniotic
fluid cause meconium passage through a local effect
on gastrointestinal activity.
A second explanation is that meconium may en-
hance the growth of bacteria in amniotic fluid or
impair host immunity, thus tipping the balance in
the host’s battle against infection. Florman and
Teubner
3 previously demonstrated that meconium
enhanced the growth of Escherichia coli, L. monocy-
togenes, and Staphylococcus aureus in vitro. More
recently, other investigators
14 have suggested that
meconium may alter zinc-to-phosphorus ratios in
amniotic fluid and thus enhance bacterial growth
and decrease host defenses.
We conclude that, compared with matched term
women with clear amniotic fluid, women in our
institution with MSAF are more likely to develop
chorioamnionitis. Accordingly, we suggest that
asymptomatic women with MSAF should be ob-
served carefully for early signs of clinical infection.
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